Department of Thoracic Surgery, The First Affiliated Hospital of Zhejiang University, Qingchun Road 79, Hangzhou, China, 310009.
Zhejiang University School of Medicine, Yuhangtang Road 866, Hangzhou, China, 310009.
Int J Med Sci. 2021 Jan 1;18(2):448-458. doi: 10.7150/ijms.51297. eCollection 2021.
Lung adenocarcinoma (LUAD) is the predominant subtype of lung cancer with a relatively poor prognosis. The dramatic improvements of new immunotherapy strategies have shown promising results in lung cancer patients. This study aimed to elucidate the functions of immune-associated genes in LUAD prognosis and pathogenesis by analyzing public databases. We obtained expression profiles of LUAD patients from The Cancer Genome Atlas (TCGA) database and applied the ESTIMATE algorithm to calculate immune scores and stromal scores. A series of microenvironment-related genes with prognostic value was then identified. Of note, heat shock factor 5 (HSF5) was found to be decreased in LUAD patients and positively correlated with overall survival, which was further confirmed in the Gene Expression Omnibus (GEO) database. Moreover, Gene Ontology (GO) analysis based on the correlated genes of HSF5 demonstrated that HSF5 expression was significantly associated with the immune response and inflammatory activities. Based on the Tumor IMmune Estimation Resource (TIMER) and Gene Expression Profiling Interactive Analysis (GEPIA) datasets, HSF5 expression showed strong correlations with various immune cell infiltration and diverse immune marker sets. These findings suggest that HSF5 can be used as a promising biomarker for determining prognosis and immune infiltration in LUAD patients.
肺腺癌 (LUAD) 是肺癌的主要亚型,预后相对较差。新的免疫治疗策略的显著改善已经在肺癌患者中显示出了有前景的结果。本研究旨在通过分析公共数据库来阐明免疫相关基因在 LUAD 预后和发病机制中的作用。我们从癌症基因组图谱 (TCGA) 数据库中获取 LUAD 患者的表达谱,并应用 ESTIMATE 算法计算免疫评分和基质评分。然后确定了一系列具有预后价值的微环境相关基因。值得注意的是,发现热休克因子 5 (HSF5) 在 LUAD 患者中降低,并与总生存期呈正相关,这在基因表达综合数据库 (GEO) 中也得到了进一步证实。此外,基于 HSF5 相关基因的基因本体 (GO) 分析表明,HSF5 的表达与免疫反应和炎症活性显著相关。基于肿瘤免疫估计资源 (TIMER) 和基因表达谱交互式分析 (GEPIA) 数据集,HSF5 表达与各种免疫细胞浸润和不同的免疫标志物集显示出强烈的相关性。这些发现表明,HSF5 可以作为 LUAD 患者确定预后和免疫浸润的有前途的生物标志物。